Cost-effectiveness of the Xpert® MTB/RIF assay for tuberculosis diagnosis in Brazil. [electronic resource]
Producer: 20170117Description: 611-8 p. digitalISSN:- 1815-7920
- Antibiotics, Antitubercular -- therapeutic use
- Automation, Laboratory
- Brazil
- Computer Simulation
- Cost-Benefit Analysis
- DNA, Bacterial -- genetics
- Decision Support Techniques
- Decision Trees
- Drug Resistance, Bacterial -- genetics
- False Positive Reactions
- Health Care Costs
- Humans
- Lung -- microbiology
- Molecular Diagnostic Techniques -- economics
- Mycobacterium tuberculosis -- drug effects
- Polymerase Chain Reaction -- economics
- Predictive Value of Tests
- Reproducibility of Results
- Rifampin -- therapeutic use
- Sputum -- microbiology
- Tuberculosis, Pulmonary -- diagnosis
- Unnecessary Procedures -- economics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.